QURE Stock Analysis: Buy, Sell, or Hold?
QURE - uniQure N.V.
$49.56
-1.39 (-2.73%)
▼
5d:
+1.37%
30d:
+23.68%
90d:
+99.44%
WAIT
LOW Confidence
Analysis Updated: Aug 27, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 27, 2026 at $49.56 · last confirmed Aug 27, 2026
Strength: 6.1/10
Get Alerted When QURE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: QURE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: QURE shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: QURE is currently trading at $49.56, which is considered extended relative to its 30-day fair value range of $40.27 to $47.95.
Technical Outlook: Technically, QURE is in a strong uptrend. Immediate support is located at $46.31, while resistance sits at $51.72.
Market Sentiment: QURE scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $70.07 (+41.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QURE is in a strong uptrend. Immediate support is located at $46.31, while resistance sits at $51.72.
Market Sentiment: QURE scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $70.07 (+41.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$40.27 -
$47.95
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
Protect Your Profits
Holding QURE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 41.4% below Wall St target ($70.07)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$40.27 -
$47.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$46.31
Resistance Level
$51.72
Current Trend
Strong Uptrend
Technical data as of
Aug 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.16
Wall Street Target
$70.07
(+41.4%)
Revenue Growth (YoY)
11.0%
Earnings Growth (YoY)
-18.2%
Share & Embed Analysis
Last updated: August 27, 2026 9:19 PM ET
Data refreshes hourly during market hours. Next update: 10:19 PM
Data refreshes hourly during market hours. Next update: 10:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QURE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeannette Potts
SELL
3412 shares
2026-03-04
Matthew C Kapusta
SELL
14581 shares
2026-03-04
Walid Abi-Saab
SELL
808 shares
2026-03-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 49 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 35 SELL |
Advanced QURE Option Strategies
Professional options setups generated by AI based on today's QURE price and gamma walls.
